Table of Contents Table of Contents
Previous Page  112 / 264 Next Page
Information
Show Menu
Previous Page 112 / 264 Next Page
Page Background

who died from intracranial complications (1 =

Klebsiella

pneumoniae

, 1 =

P aeruginosa

; 1 = negative culture).

Based on culture sensitivity, 52.6% (n = 10) received

culture-specific therapy. Those with negative cultures

received empirical intravenous ceftazidime and oral fluoro-

quinolone. The mean (SD) duration of antibiotic therapy

was 42.2 (15.3) days. Outpatient therapy was used in 63.2%

(n = 12) to reduce inpatient stay, reducing the mean (SD)

inpatient antibiotic duration to 24.3 (20.1) days.

There was no statistically significant difference in out-

come between those who received culture-specific therapy

and those who received ceftazidime and fluoroquinolone

empirically (70.0% of the directed therapy group had dis-

ease that resolved vs 55.6% in the empirical therapy group;

P

= .650).

Discussion

Malignant otitis externa had associated mortality rates of

50% when it was first characterized in 1968.

1

The develop-

ment of anti-pseudomonal antibiotics has since reduced

mortality significantly. Studies have reviewed factors such

as clinical presentation, laboratory and imaging findings,

and microbiology in an attempt to identify prognostic fac-

tors. However, conclusive prognostic factors have yet to be

identified, and there is still no consensus on the optimal

choice of antibiotics and duration of therapy.

Demographic Factors

The impact of age on prognosis is disputed. Franco-Vidal et

al

5

reviewed 46 patients and found that age did not affect

outcome. On the contrary, Soudry et al

4

studied 57 patients,

and their results suggested a lower life expectancy for those

aged 70 years and older. However, this was also attributed

to additional risks contributed by diabetes and other

atherosclerosis-related comorbidities frequently present in

these patients. Our experience suggests that age is not an

accurate prognostic factor.

The link with diabetes is well established,

1,6

with recent

studies reporting the prevalence of diabetes in MOE to be

between 65% and 95%.

4,5,7

Our results concurred, with

94.7% (n = 18) having diabetes in our study. Diabetes-

related microangiopathy is thought to predispose to MOE as

the impaired local circulation within the EAC diminishes

the ability of immunological cells to respond to invasion by

P aeruginosa.

8,9

Glycemic control is linked to the severity

of microangiopathy in the retina and renal circulations.

Hence, we postulated that poorer glycemic control would

imply more severe microangiopathy within the EAC, and

this could predict severe disease. However, analysis of

HbA1c levels failed to show relation to outcome. This con-

curs with earlier studies that also failed to show any relation

between degree of glucose intolerance and outcome.

6,9

A

possible explanation could be that as most patients are

elderly with longstanding diabetes, microangiopathy within

the EAC is already end stage, therefore making little differ-

ence in the local immune response.

Presentation

Initial symptoms are indistinguishable from simple otitis

externa. It is usually only after multiple failed treatment

attempts that MOE is suspected. The mean diagnostic delay

was significantly long at 6.79 weeks, similar to the literature,

which has been reported to be between 1 and 7 months.

10,11

Similar to other studies,

4,12

our results suggest that a delay in

the commencement of intravenous antibiotics does not

adversely affect outcome. However, this delay leads to pro-

longed suffering, and physicians should always maintain a

high index of suspicion in susceptible patients.

Soudry et al

4

and Franco-Vidal et al

5

found that those

with facial nerve palsy at presentation had a poorer out-

come. This trend was noted in our series, but the number of

patients with facial nerve involvement was small, and the

findings did not reach statistical significance (50.0% poor

outcome in the group with cranial nerve involvement vs

33.3% poor outcome in the group without;

P

= .603).

Hematological Parameters

Leukocytosis, a traditional marker of inflammation, was not

prominent, and its use in monitoring activity is limited. In

contrast, the usefulness of CRP and ESR as markers for

activity is apparent, concurring with previous studies.

3,6

Our

results showed that the absolute ESR and CRP levels could

not be relied upon alone to predict outcome, but the useful-

ness of these markers became evident when serial readings

showed that trends were seen to correlate closely with disease

activity. Patients with disease that resolved after 6 weeks of

intravenous therapy showed a 21.71% reduction in mean

ESR values compared with the group with persistent disease,

in which ESR values remained unchanged (

Figure 1

). A

similar downward trend was also seen in CRP levels. By

trending inflammatory marker levels, clinicians are able to

decide more confidently which patients are suitable for anti-

biotic cessation or outpatient treatment, especially when one

does not have ready access to radionuclide scans.

Imaging Findings

Radionuclide bone and white cell–tagged scans have proven

valuable in MOE. Bone scans are sensitive because the

radionuclide tracer (technetium-99m methylene diphospho-

nate) accumulates at areas of osteoblastic activity. However,

osteoblastic activity persists long after the infective process,

hence limiting the usefulness for charting progress or con-

firming resolution. White cell–tagged scans using gallium

citrate (Ga67) have been more useful in monitoring disease

as the tracer is incorporated directly into granulocytes at

sites of infection. These scans are undoubtedly valuable;

however, they may not be available in all institutions deal-

ing with MOE. In our experience, we have used anatomic

imaging modalities such as CT and MRI to assess our

patients.

Computed tomography is ideal for assessing bony invol-

vement. In theory, the anatomical extent of disease should

be useful for prognosis. Peleg et al

13

reported that severe

Otolaryngology–Head and Neck Surgery 148(6)

91